Avoid Falling in Love with Your Own Hypothesis

Courtesy of Adriano Aguzzi Early Indication: I was fascinated by life sciences in high school. Medical school failed to provide me with sufficient background knowledge in the natural sciences to successfully pursue a career as a scientist, so I engaged in all sorts of extracurricular activities in laboratories while I was a medical student. How I Got Here: My medical background proved very useful for research activity in the neurosciences, which has become my mission in the last 15 years. Wh

Written byAdriano Aguzzi
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Early Indication: I was fascinated by life sciences in high school. Medical school failed to provide me with sufficient background knowledge in the natural sciences to successfully pursue a career as a scientist, so I engaged in all sorts of extracurricular activities in laboratories while I was a medical student.

How I Got Here: My medical background proved very useful for research activity in the neurosciences, which has become my mission in the last 15 years. When I started out, I did not spend much time thinking about my career. I was simply fascinated by the possibility of modeling human diseases in transgenic mice.

Pivotal Paper: The first molecular paper for which I can claim full intellectual fathership was the description of a new tumor entity in transgenic mice expressing a viral oncogene (K. Khazaie et al., "EGF promotes in vivo tumorigenic growth of primary chicken-embryo fibroblasts expressing v-myc and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies